Lyophilized Boron Complex Powder for BNCT Solubility

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current boron-containing drugs for boron neutron capture therapy are insoluble and prone to precipitation, limiting their effectiveness and storage stability, necessitating a method to enhance solubility without compromising the boron complex.

Innovation Solution

A lyophilized powder containing a boron complex formed by a dehydration condensation reaction between a dihydroxyboryl compound and a sugar or sugar alcohol, with specific molar ratios and pH conditions, is developed, allowing for improved solubility and stability through complex formation and vacuum drying processes.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If boron-containing drugs are used for boron neutron capture therapy, then tumor cell selectivity is improved, but solubility deteriorates

Engineering Contradiction:
Improvetumor cell selectivityVSAvoidsolubility
Core Design Contradiction:
ReliabilityVSQuantity of substance

Solution Approach 1:

The patent uses sugars (glucose, fructose, galactose) and sugar alcohols (sorbitol, mannitol, xylitol) as intermediary molecules to form complexes with dihydroxyboryl compounds. These carbohydrate intermediaries provide hydrophilic groups that enhance water solubility while maintaining the boron-containing therapeutic agent's ability to target tumor cells selectively through the boron neutron capture therapy mechanism.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Reliability

If boron-containing drugs are formulated for therapy, then therapeutic effectiveness is improved, but storage stability deteriorates

Engineering Contradiction:
Improvetherapeutic effectivenessVSAvoidstorage stability
Core Design Contradiction:
ReliabilityVSStability of the object's composition

Solution Approach 1:

The patent creates composite materials by forming complexes between dihydroxyboryl compounds and carbohydrates. The composite structure combines the therapeutic boron-containing agent with stabilizing sugar molecules, resulting in a formulation that maintains both therapeutic effectiveness and improved storage stability by preventing precipitation and degradation.

Inventive Principle:
Principle #40Composite materials

3Quantity of substance

If complex formation is used to improve solubility, then solubility is improved, but manufacturing complexity increases

Engineering Contradiction:
ImprovesolubilityVSAvoidmanufacturing complexity
Core Design Contradiction:
Quantity of substanceVSDevice complexity

Solution Approach 1:

The patent segments the manufacturing process into distinct, manageable steps: (1) mixing the dihydroxyboryl compound with sugar or sugar alcohol, (2) allowing spontaneous complex formation through dehydration condensation reaction, and (3) freeze-drying the resulting solution. This segmentation simplifies manufacturing by breaking down the complex formation process into basic, easily controlled operations.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The complex formation process is designed to occur spontaneously when the dihydroxyboryl compound and carbohydrate are mixed in aqueous solution. The dehydration condensation reaction proceeds automatically under physiological conditions without requiring additional catalysts, energy input, or complex processing equipment, allowing the system to self-assemble the soluble complex.

Inventive Principle:
Principle #25Self-service

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The lyophilized powder exhibits excellent solubility, stability, and pH compatibility for physiological applications, maintaining over 99% purity and dissolving quickly in water, making it suitable for boron neutron capture therapy without further processing.

Implementation Method 1

a complex formed by a dehydration condensation reaction of a dihydroxyboryl compound and a sugar or a sugar alcohol

Methodology Applied
Scientific EffectDehydration condensation reaction: Chemical Bonding

Implementation Method 2

The mixture is immersed into liquid nitrogen to freeze the mixture to form a pre-frozen body

Methodology Applied
Scientific EffectFreezing: Freezing

Implementation Method 3

A vacuum drying process is performed to evaporate water from the pre-frozen body to form the lyophilized powder

Methodology Applied
Scientific EffectEvaporation: Evaporation

Implementation Method 4

A vacuum drying process is performed to evaporate water from the pre-frozen body to form the lyophilized powder

Methodology Applied
Scientific EffectSublimation: Sublimation

Data Source

PatentUS20240307421A1Lyophilized powder containing boron complex and method of forming the same
Publication Date: 2024.09.19 HERON NEUTRON MEDICAL CORP
  • US20240307421A1 patent drawing
  • US20240307421A1 patent drawing
  • US20240307421A1 patent drawing

AI summary

The present disclosure provides a lyophilized powder containing a boron complex. The lyophilized powder includes a sugar acid and a complex formed by a dehydration condensation reaction of a dihydroxyboryl compound and a sugar or a sugar alcohol. The present disclosure also provides a method of forming a lyophilized powder containing a boron complex. The method includes the following operations. A dihydroxyboryl compound and a sugar or a sugar alcohol are mixed to form a mixture, and the mixture includes a complex formed by a dehydration condensation reaction of the dihydroxyboryl compound and the sugar or the sugar alcohol. The mixture is immersed in liquid nitrogen to freeze the mixture to form a pre-frozen body. A vacuum drying process is performed to evaporate water of the pre-frozen body to form a lyophilized powder.